Dr. Ranjeet Bajpai, MD, DNB

• Precision radiation treatment for various malignancies including SBRT & Adaptive radiotherapy for Head & Neck, Breast, Thoracic GI, Prostate, Gynaecological and Brain Cancers.
• Healthcare data analysis/management, Healthcare policy making and Clinical research.
• Preventive Oncology & Public health.
• Artificial Intelligence & use of Big Data in Clinical research.

18 years experience in managing cancer patients at centers of excellence, managing manpower involved in the healthcare delivery, carrying out research and educational activities and coordinating clinical activities in a multi-specialty hospital set-up.

• Linear Accelerators – Ethos, TrueBeam, TrueBeam STx and Clinac 2100/2300CD (Varian).
• Eclipse planning system (Varian).
• Brachytherapy (Nucletron) and VariSource (Varian).
• Stereotactic Radiotherapy and Stereotactic Radiosurgery: Gamma Knife, TrueBeam STx, Eclipse and Brain lab I-Plan planning system.
• Cobalt 60 machine – Theratron 780 C.

• Adaptive Radiotherapy – offline & online.
• 3DCRT, IMRT, VMAT & rapid arc planning, contouring, plan reviews and treatment.
• Brachytherapy-Intra-cavitary and Interstitial brachytherapy in Gynecological cancers, Intraluminal brachytherapy (Esophageal cancers).
• Stereotactic radiation therapy and Radio surgery.
• Deep inspiration breath hold (DIBH) and prone breast radiotherapy technique for breast cancers.

• Medical Council of India (MCI)
• Maharashtra Medical Council (MMC)

• Association of Radiation Oncologists of India (AROI) since 2004.
•  European Society for Radiotherapy & Oncology (ESTRO) since 2008.
• American Society for Radiation Oncology (ASTRO) since 2008.

1. Fellow at Sjaelland University Hospital, Copenhagen, Denmark, March - Oct 2022.
2. Short term training at University Hospital, Geneva for Prone breast radiation in Nov 2016.
3. Visiting Fellowship for a week at National Cancer Institute (NCI), Bethesda, MD, USA, under ‘2008 ASTRO international-U.S. Annual Meeting Travel Grant’ in September 2008.
4. Short-term training at the Department of Radiotherapy, All India Institute of Medical Sciences (AIIMS), New Delhi, for a period of one month in January 2006.
5. Completed training for a period of one year and three months at Department of Radiotherapy, King George Medical University (KGMU), Lucknow from September 2004 to November 2005, as part of the MD Programme.

1. ASTRO International–US Annual Meeting Travel Grant (2008): Single recipient awardee for the ASTRO Annual Meet, held in Boston in September 2008.
2. Best Paper Award (2008): UPAROI, Lucknow, India. Paper titled “The Quality of Recording of Patient Demography; Compliance to Radiotherapy, Morbidity Reporting and Status of Follow-up of Head and Neck Cancer Patients”.
3. Travel Fellowship (2005): AROI, Ahmedabad, India. Paper titled “Role of Percutaneous Endoscopic Gastrostomy for enteral nutrition in patients with head and neck cancers on intensive chemo-radiation protocols - A feasibility study”.
4. Best Paper Award (2005): AROI, Ahmedabad, India. Paper entitled “Role of VFG in assessing functional abnormalities in patients of head and neck cancer treated with chemo-radiotherapy”.

1. Bajpai R, Bajpai J. Closing the research gaps in obstetric health for survivors of cancer. Lancet Oncol. 2024 Aug;25(8):953-955. doi: 10.1016/S1470-2045(24)00321-8. Epub 2024 Jun 26. PMID: 38944049.
2. Venkatesan K, Anand V, Bajpai R, Kabre RS, Kapadia A, Almel S, et al. A single-institution retrospective analysis of outcomes for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. J Radiat Cancer Res 2020;11:81-9.
3. Gupta PK, Lal P, Bajpai R, Goel A, Yadav R, Verma M, Kumar S. Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer. South Asian J Cancer. 2016 Apr-Jun;5(2):80-4.
4. Kannan V, Bajpai R. Conforming Modern Radiation Oncology Facilities to the Irregular Contours of the Vast & Varied Nation of India. Int. J. Radiation Oncology, Biology, Physics Vol.94, No. 4, pp 645-651, 2016.
5. Lal P, Bajpai R, Khurana R, Das KJ, Kumar P, Tiwari A, Gupta N, Kumar S. Changes in salivary flow rates in head and neck cancer after chemoradiotherapy. J Cancer Res Ther. 2010 Oct-Dec;6(4):458-62.
6. Agrawal S, Bajpai R, Agrawal RK, Gupta TC. Bilateral synchronous seminoma with bilateral cryptorchidism of the testis. Indian J Urol. 2010 Oct;26(4):587-9.
7. Lal P, Tiwari A, Verma A, Das KJ, Baijal SS, Bajpai R, Kumar P, Srivastava A, Kumar S. Role of video-fluorography in assessing functional abnormalities in patients of head and neck cancer treated with chemoradiotherapy. Asia-Pacific Journal of Clinical Oncology 2009; 5:264-269.
8. Bajpai R, Srivastava A, Lal P, Kumar S. Defining the Standard of Care: Waiting Times, Data Recording, Adverse Effects Reporting, Radiotherapy Compliance and Follow-up of Head and Neck Cancer Patients, at a Tertiary Cancer Center in India. Int J. Radiation Oncology, Biology, Physics 2008; 72:S412-413.
9. Tiwari A, Kumar N, Bajpai R, Lal P. Bone metastasis from ovarian cancer. Journal of Cancer Research and Therapeutics 2007; 3:34-36.

1. Neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. ESTRO 2024 s1064:2182.
2. Comparison of heart and lung doses in deep inspiration breath hold radiotherapy and prone position radiotherapy for whole breast radiation therapy. Poster #: TU_26_3149. Proceedings ASTRO 2018, San Antonio, Texas.
3. Use of Portal dosimetry to monitor treatment consistency throughout the course of treatment. Poster: E36-0720. Proceedings ESTRO 2017, Vienna, Austria.
4. Outcomes in Medulloblastoma: Single institution case series: Neuro-Oncology 16:V188-V196, 2014. Proceedings SNO 2014, held in Miami, USA in Nov 2014.
5. ‘Treatment outcome for Germ cell tumor (GCT) Brain’ – Neuro-Oncology 16:i30–i39, 2014. Proceedings ISPNO 2014, held in Singapore in June 2014.
6. ‘Patterns of outcome in treatment of stomach cancer’, Indian Cancer Congress, New Delhi, India in Nov 2013.
7. ‘Chemo-radiotherapy offers better quality of life and survival outcome compared to surgery in muscle invasive bladder cancer’. RGCON, held in New Delhi, India. March 2010.
8. ‘Does addition of chemotherapy or accelerated radiotherapy benefits in oral cancer lesions- a retrospective audit’. J Oral Oncology Supplement, 2009, 3: 188-89. Poster presented at Second World Congress of the International Academic of Oral Oncology in July 2009.
9. ‘The standard of care: waiting times, data recording, adverse effects reporting, radiotherapy compliance, and follow-up of head & neck cancer patients, at a tertiary cancer center in India’. ASTRO Annual Meeting, held in Boston, USA September 2008.
10. ‘Does the use of Percutaneous Endoscopic Gastrostomy (Peg) improve compliance to intensive Chemo-Radiotherapy’. (Crt) Protocols in Advanced Head-Neck Cancers. World Cancer Congress, UICC, held in Washington DC, 2006.
11. ‘Six fractions a-week radiotherapy along with concurrent weekly cisplatin in locally advanced head and neck cancer’. ESTRO meeting 2006.
12. ‘Changes in basal and stimulated salivary flow rates in patients of head and neck cancer treated with conventional radiotherapy techniques. ESTRO meeting 2006 (Co-author in the study).
13. ‘Role of Percutaneous Endoscopic Gastrostomy for enteral nutrition in patients with head and neck cancers on intensive chemo-radiation protocols - A feasibility study’. Annual Conference of the Association of Radiation Oncologists of India (AROICON 2005), held in Ahmedabad, India, December 2005.

Actively involved as Panelist/ Expert speaker at various national & international meetings.

1. Invited Faculty at Year in review Breast held at Tata Memorial Centre in Jan 2024.
2. Invited Faculty at Indian Cancer Congress, Mumbai in Nov 2023.
3. Invited Faculty at National Liver ‘BUILD’ conference in Jan 2023 & Jan 2024.
4. ‘Post-operative Prostate cancer’ at Best of ASTRO 2018-India in June 2019, Kolkata, India.
5. ‘GU cancer symposium’ at Best of ASCO- India, June 2019, Mumbai, India.
6. ‘Oncotype score in post-mastectomy radiotherapy’ at Best of ASTRO 2017-India in May 2018, New Delhi, India.
7. Invited speaker at 12th International Conference of the Asian Clinical Oncology Society (ACOS 2016) held at New Delhi in April 2016.
8. ‘Current concepts in management of Low Grade Gliomas’ at ISMPO, Mumbai, 2015.
9. Invited speaker for First ‘Best of ASTRO’ at KDAH, Mumbai, May 2015.
10. ‘Evaluation of 3D-CRT/IMRT for cranio-spinal irradiation in supine position’. 2nd Neuro- Oncology society of India meeting held in Chennai, India from April 2-4, 2010.
11. ‘The Quality of Recording of Patient Demography; Compliance to Radiotherapy, Morbidity Reporting and Status of Follow-up of Head and Neck Cancer Patients’. Annual Conference of the Association of Radiation Oncologists of India, UP chapter, Lucknow 2008.
12. ‘Role of Percutaneous Endoscopic Gastrostomy for enteral nutrition in patients with head and neck cancers on intensive chemo-radiation protocols - A feasibility study’. Annual Conference of the Association of Radiation Oncologists of India (AROICON 2005), held in Ahmedabad, India, December 2005.